Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering

Background: Globally, gastric cancer (GC) is the fifth most common tumor. It is necessary to identify novel molecular subtypes to guide patient selection for specific target therapeutic benefits. Methods: Multi-omics data, including transcriptomics RNA-sequencing (mRNA, LncRNA, miRNA), DNA methylati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xianyu Hu, Zhenglin Wang, Qing Wang, Ke Chen, Qijun Han, Suwen Bai, Juan Du, Wei Chen
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/141e76a7211c444ab15b459d35d71973
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:141e76a7211c444ab15b459d35d71973
record_format dspace
spelling oai:doaj.org-article:141e76a7211c444ab15b459d35d719732021-11-14T04:28:40ZMolecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering0753-332210.1016/j.biopha.2021.112222https://doaj.org/article/141e76a7211c444ab15b459d35d719732021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0753332221010064https://doaj.org/toc/0753-3322Background: Globally, gastric cancer (GC) is the fifth most common tumor. It is necessary to identify novel molecular subtypes to guide patient selection for specific target therapeutic benefits. Methods: Multi-omics data, including transcriptomics RNA-sequencing (mRNA, LncRNA, miRNA), DNA methylation, and gene mutations in the TCGA-STAD cohort were used for the clustering. Ten classical clustering algorithms were executed to recognize patients with different molecular features using the “MOVICS” package in R. The activated signaling pathways were evaluated using the single-sample gene set enrichment analysis. The differential distribution of gene mutations, copy number alterations, and tumor mutation burden was compared, and potential responses to immunotherapy and chemotherapy were also assessed. Results: Two molecular subtypes (CS1 and CS2) were recognized by ten clustering algorithms with consensus ensembles. Patients in the CS1 group had a shorter average overall survival time (28.5 vs. 68.9 months, P = 0.016), and progression-free survival (19.0 vs. 63.9 months, P = 0.008) as compared to those in the CS2 group. Extracellular associated biological process activation was higher in the CS1 group, while the CS2 group displayed the enhanced activation of cell cycle-associated pathways. Significantly higher total mutation numbers and neoantigens were observed in the CS2 group, along with specific mutations in TTN, MUC16, and ARID1A. Higher infiltration of immunocytes was also observed in the CS2 group, reflective of the potential immunotherapeutic benefits. Moreover, the CS2 group could also respond to 5-fluorouracil, cisplatin, and paclitaxel. The similar diversity in clinical outcomes between CS1 and CS2 groups was successfully validated in the external cohorts, GSE62254, GSE26253, GSE15459, and GSE84437. Conclusion: The findings provided novel insights into the GC subtypes through integrative analysis of five -omics data by ten clustering algorithms. These could provide potential clinical therapeutic targets based on the specific molecular features.Xianyu HuZhenglin WangQing WangKe ChenQijun HanSuwen BaiJuan DuWei ChenElsevierarticleGastric cancerMolecular classificationMulti-omicsOverall survivalGene mutationTherapeutics. PharmacologyRM1-950ENBiomedicine & Pharmacotherapy, Vol 144, Iss , Pp 112222- (2021)
institution DOAJ
collection DOAJ
language EN
topic Gastric cancer
Molecular classification
Multi-omics
Overall survival
Gene mutation
Therapeutics. Pharmacology
RM1-950
spellingShingle Gastric cancer
Molecular classification
Multi-omics
Overall survival
Gene mutation
Therapeutics. Pharmacology
RM1-950
Xianyu Hu
Zhenglin Wang
Qing Wang
Ke Chen
Qijun Han
Suwen Bai
Juan Du
Wei Chen
Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering
description Background: Globally, gastric cancer (GC) is the fifth most common tumor. It is necessary to identify novel molecular subtypes to guide patient selection for specific target therapeutic benefits. Methods: Multi-omics data, including transcriptomics RNA-sequencing (mRNA, LncRNA, miRNA), DNA methylation, and gene mutations in the TCGA-STAD cohort were used for the clustering. Ten classical clustering algorithms were executed to recognize patients with different molecular features using the “MOVICS” package in R. The activated signaling pathways were evaluated using the single-sample gene set enrichment analysis. The differential distribution of gene mutations, copy number alterations, and tumor mutation burden was compared, and potential responses to immunotherapy and chemotherapy were also assessed. Results: Two molecular subtypes (CS1 and CS2) were recognized by ten clustering algorithms with consensus ensembles. Patients in the CS1 group had a shorter average overall survival time (28.5 vs. 68.9 months, P = 0.016), and progression-free survival (19.0 vs. 63.9 months, P = 0.008) as compared to those in the CS2 group. Extracellular associated biological process activation was higher in the CS1 group, while the CS2 group displayed the enhanced activation of cell cycle-associated pathways. Significantly higher total mutation numbers and neoantigens were observed in the CS2 group, along with specific mutations in TTN, MUC16, and ARID1A. Higher infiltration of immunocytes was also observed in the CS2 group, reflective of the potential immunotherapeutic benefits. Moreover, the CS2 group could also respond to 5-fluorouracil, cisplatin, and paclitaxel. The similar diversity in clinical outcomes between CS1 and CS2 groups was successfully validated in the external cohorts, GSE62254, GSE26253, GSE15459, and GSE84437. Conclusion: The findings provided novel insights into the GC subtypes through integrative analysis of five -omics data by ten clustering algorithms. These could provide potential clinical therapeutic targets based on the specific molecular features.
format article
author Xianyu Hu
Zhenglin Wang
Qing Wang
Ke Chen
Qijun Han
Suwen Bai
Juan Du
Wei Chen
author_facet Xianyu Hu
Zhenglin Wang
Qing Wang
Ke Chen
Qijun Han
Suwen Bai
Juan Du
Wei Chen
author_sort Xianyu Hu
title Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering
title_short Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering
title_full Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering
title_fullStr Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering
title_full_unstemmed Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering
title_sort molecular classification reveals the diverse genetic and prognostic features of gastric cancer: a multi-omics consensus ensemble clustering
publisher Elsevier
publishDate 2021
url https://doaj.org/article/141e76a7211c444ab15b459d35d71973
work_keys_str_mv AT xianyuhu molecularclassificationrevealsthediversegeneticandprognosticfeaturesofgastriccanceramultiomicsconsensusensembleclustering
AT zhenglinwang molecularclassificationrevealsthediversegeneticandprognosticfeaturesofgastriccanceramultiomicsconsensusensembleclustering
AT qingwang molecularclassificationrevealsthediversegeneticandprognosticfeaturesofgastriccanceramultiomicsconsensusensembleclustering
AT kechen molecularclassificationrevealsthediversegeneticandprognosticfeaturesofgastriccanceramultiomicsconsensusensembleclustering
AT qijunhan molecularclassificationrevealsthediversegeneticandprognosticfeaturesofgastriccanceramultiomicsconsensusensembleclustering
AT suwenbai molecularclassificationrevealsthediversegeneticandprognosticfeaturesofgastriccanceramultiomicsconsensusensembleclustering
AT juandu molecularclassificationrevealsthediversegeneticandprognosticfeaturesofgastriccanceramultiomicsconsensusensembleclustering
AT weichen molecularclassificationrevealsthediversegeneticandprognosticfeaturesofgastriccanceramultiomicsconsensusensembleclustering
_version_ 1718430000968892416